PEAK6 Investments L.P. raised its stake in shares of China Cord Blood Corp (NYSE:CO) by 119.6% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 385,679 shares of the medical research company’s stock after purchasing an additional 210,022 shares during the quarter. PEAK6 Investments L.P.’s holdings in China Cord Blood were worth $3,838,000 as of its most recent filing with the Securities and Exchange Commission.
Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Ameriprise Financial Inc. acquired a new stake in China Cord Blood during the third quarter valued at approximately $3,881,000. Nationwide Fund Advisors acquired a new position in shares of China Cord Blood in the 3rd quarter worth approximately $372,000. California Public Employees Retirement System boosted its holdings in shares of China Cord Blood by 32.6% in the 3rd quarter. California Public Employees Retirement System now owns 182,609 shares of the medical research company’s stock worth $2,031,000 after acquiring an additional 44,909 shares in the last quarter. Wells Fargo & Company MN boosted its holdings in shares of China Cord Blood by 1,260,105.6% in the 3rd quarter. Wells Fargo & Company MN now owns 226,837 shares of the medical research company’s stock worth $2,522,000 after acquiring an additional 226,819 shares in the last quarter. Finally, Arrowstreet Capital Limited Partnership boosted its holdings in shares of China Cord Blood by 81.5% in the 4th quarter. Arrowstreet Capital Limited Partnership now owns 599,431 shares of the medical research company’s stock worth $5,964,000 after acquiring an additional 269,125 shares in the last quarter. 21.95% of the stock is currently owned by institutional investors.
China Cord Blood Corp (NYSE:CO) opened at $11.15 on Wednesday. The company has a market capitalization of $1,317.00, a P/E ratio of 32.12 and a beta of 0.88. China Cord Blood Corp has a 1-year low of $5.06 and a 1-year high of $14.95.
About China Cord Blood
China Cord Blood Corporation is a provider of cord blood banking services in China. The Company and its subsidiaries are principally engaged in the provision of umbilical cord blood storage and ancillary services in the People’s Republic of China. It provides cord blood testing, processing and storage services under the direction of subscribers for a cord blood processing fee and a storage fee.
Want to see what other hedge funds are holding CO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for China Cord Blood Corp (NYSE:CO).
Receive News & Ratings for China Cord Blood Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Cord Blood and related companies with MarketBeat.com's FREE daily email newsletter.